Soligenix; Announcing New FDA Drug Application Submission for Cutaneous T-cell Lymphoma

(5:37)

Soligenix; Announcing Successful Protection Using a Bivalent Thermostabilized Filovirus Vaccine

(3:52)

Soligenix; Announcing Formation of Psoriasis Medical Advisory Board

(4:43)

Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

(6:31)

Soligenix Investor Overview

(1:37)

Soligenix, Inc - Superlative Performance in Rare Diseases

(34:41)

Soligenix Updates on Heat-Stable Vaccines and Oncology Advances

(6:45)

Soligenix's Mission in Biotech: An Interview with CEO Dr. Chris Schaber

(8:25)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Quebec premier welcomes U.S. tariff delay but decries uncertainty

(2:13)

This Week on RedChip TV: Sharps Technology, Reviva Pharmaceuticals \u0026 American Resources Corporation

(27:2)

RedChip TV Highlights Soligenix Inc. (NASDAQ: SNGX) \u0026 ASP Isotopes (NASDAQ: ASPI) This Week

(27:)

These are the stocks to buy for the next 10 years

(5:32)

This Week on RedChip TV: Soligenix (SNGX) \u0026 Unicycive Therapeutics (UNCY)

(27:2)

Bullish Technicals Hold in Volatile Session, OKLO's A.I. Power Flex

(6:3)

Soligenix (Nasdaq:SNGX) Business Update \u0026 Fireside Chat With PCGAdvisory

(42:11)

RedChip TV Highlights Soligenix Inc. (NASDAQ: SNGX) \u0026 Sharps Technologies (NASDAQ: STSS)

(27:1econd)

Bear Case for Trump on U.S. Stocks \u0026 Tariff Impact on Markets

(10:44)

Learn Why Soligenix has Received $60M+ in Non-Dilutive Funding From the US Government: CEO Interview

(10:1econd)

Soligenix: A Late-Stage Biopharma Pioneer Tackling Rare Diseases with Unmet Needs

(23)

Learn Why Soligenix Has Recieved Over $60M in NIH and Other Government Grants

(31)

Inside Soligenix: Innovations in Rare Disease Therapies

(2:11)

FDA Grants Soligenix Fast Track Designation for Dusquetide in the Treatment of Oral Lesions

(1:11)

Soligenix; Diving into Dusquetide with Chief Scientific Officer Oreola Donini

(2:47)

SOLIGENIX PODCAST VIDEO

(8:5)

Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

(12:1econd)

RedChip Investor Group Call with Soligenix (NASDAQ: SNGX)

(40)

Soligenix: Developing \u0026 Commercializing Treatments for Rare Diseases with Unmet Needs

(2:6)

RedChip Investor Group Call with Soligenix (NASDAQ: SNGX)

(48:58)